Back to mobile site

Canaccord Genuity Reiterates a 'Buy' on Stryker (SYK); MedSurg to the Rescue (Again), Recon Weak Industry-wide

January 25, 2012 9:37 AM EST
Get Alerts SYK Hot Sheet
Price: $334.81 -1.52%

Rating Summary:
    33 Buy, 13 Hold, 1 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 10 | Down: 12 | New: 19
Join SI Premium – FREE
Canaccord Genuity reiterates a 'Buy' on Stryker (NYSE: SYK) price target cut from $69.50 to $67.50.

Analyst, William J. Plovanic, said, "We continue to be long-term buyers of Stryker given its ability to navigate cyclical trends across its business units. Product diversification once again allowed Stryker to turn in an in-line quarter despite a significant slowdown across its reconstruction business unit, with strength again coming from its MedSurg franchise. Additionally, we believe synergies from recent acquisitions will drive growth and operating leverage through 2012."

For an analyst ratings summary and ratings history on Stryker click here. For more ratings news on Stryker click here.

Shares of Stryker closed at $52.94 yesterday.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst Comments